Table 6.
Univariate logistic regression analysis showing the impact of variables on time to treatment.
| Parameter | P |
|---|---|
| Age≥60 yr | 0.133 |
| Sex, male | 0.334 |
| Hemoglobin<10 g/dL | 0.044 |
| Absolute lymphocyte count>50×109/L | 0.319 |
| Platelet count<100×109/L | 0.594 |
| Hepatomegaly | 0.015 |
| Splenomegaly | 0.068 |
| Lymph node groups involved≥3 | <0.001 |
| Modified Rai stage (low vs. intermediate/high) | 0.029 |
| Binet stage (A vs. B/C) | <0.001 |
| ECOG performance status (0–1 vs. 2–4) | 0.383 |
| Lactate dehydrogenase level, normal/elevated | 0.006 |
| β2-microglobulin level, normal/elevated | <0.001 |
| CD38 expression≥30% | 0.383 |
| Cytogenetic risk group (low vs. intermediate/high) | 0.015 |